Related Experiment Video
Updated: Jun 14, 2026

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
Verapamil inhibits the glucose transport activity of GLUT1
Larry L Louters1, Nathan Stehouwer, Janelle Rekman
1Department of Chemistry & Biochemistry, Calvin College, Grand Rapids, MI, USA.
Abstract:
Calcium channel blocker toxicity has been associated with marked hyperglycemia responsive only to high-dose insulin therapy. The exact mechanism(s) of this induced hyperglycemia has not been clearly delineated. The glucose transporter GLUT1 is expressed in a wide variety of cell types and is largely responsible for a basal level of glucose transport. GLUT1 also is activated by cell stress. The specific purpose of this study was to investigate the effects of the calcium channel blocker verapamil on the glucose uptake activity of GLUT1 in L929 fibroblasts cells. Dose-dependent effects of verapamil on glucose uptake were studied using L929 fibroblast cells with 2-deoxyglucose. Verapamil had a dose-dependent inhibitory effect on both basal and stress-activated transport activity of GLUT1. Basal activity was inhibited 50% by 300 μM verapamil, while 150 μM verapamil completely inhibited the activation induced by the stress of glucose deprivation. These effects were reversible and required verapamil to be present during the stress. Alteration of calcium concentrations by addition of 5 mM CaCl₂ or 4 mM EDTA had no effect on verapamil action. This study reveals the unique finding that verapamil has inhibitory effects on the transport activity of GLUT1 independent of its effects on calcium concentrations. The inhibition of GLUT1 may be one of the contributing factors to the hyperglycemia observed in CCB poisoning.
Insights
Calcium channel blockers like verapamil can cause hyperglycemia by inhibiting the glucose transporter GLUT1. This effect on glucose uptake is independent of calcium levels and may explain toxicity symptoms.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Calcium channel blocker (CCB) toxicity is linked to severe hyperglycemia.
- The precise mechanisms behind CCB-induced hyperglycemia remain unclear.
- Glucose transporter 1 (GLUT1) mediates basal and stress-induced glucose uptake.
Purpose of the Study:
- To investigate the impact of the CCB verapamil on GLUT1 glucose uptake activity.
- To determine if verapamil affects basal and stress-activated GLUT1 transport.
Main Methods:
- Utilized L929 fibroblast cells and 2-deoxyglucose to measure glucose uptake.
- Administered varying doses of verapamil to assess dose-dependent effects.
- Studied verapamil's action under basal and glucose deprivation stress conditions.
Main Results:
- Verapamil exhibited a dose-dependent inhibition of GLUT1 glucose uptake.
- Both basal and stress-activated GLUT1 transport were suppressed by verapamil.
- Inhibition was reversible and dependent on verapamil presence during stress; calcium levels did not influence verapamil's action.
Conclusions:
- Verapamil directly inhibits GLUT1 transport activity, independent of calcium modulation.
- This inhibition of GLUT1 may contribute to the hyperglycemia seen in CCB poisoning.
- Findings offer a novel mechanistic insight into CCB toxicity.
More Related Videos
07:04Measuring Uptake of the Glucose Analog, 6-(N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino)-6-Deoxyglucose, in Intact Murine Neural Retina
Published on: March 14, 2025
07:18Visualizing Monocarboxylates and Other Relevant Metabolites in the Ex Vivo Drosophila Larval Brain Using Genetically Encoded Sensors
Published on: October 27, 2023
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are typically...
Glucose Absorption Into the Small Intestine
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Dipeptidyl Peptidase 4 Inhibitors
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Membrane Proteins